Aimei Health Technology (NASDAQ:AFJK) Stock Price Up 0.4% – Here’s What Happened

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK)’s share price shot up 0.4% during trading on Tuesday . The company traded as high as $36.99 and last traded at $33.49. 4,450 shares traded hands during mid-day trading, a decline of 34% from the average session volume of 6,708 shares. The stock had previously closed at $33.34.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on AFJK shares. Wall Street Zen upgraded Aimei Health Technology to a “sell” rating in a report on Saturday, January 17th. Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Aimei Health Technology presently has an average rating of “Sell”.

Aimei Health Technology Stock Up 2.5%

The company’s 50-day simple moving average is $51.60 and its 200 day simple moving average is $27.82. The company has a market capitalization of $188.13 million, a P/E ratio of 146.39 and a beta of -2.95.

Institutional Trading of Aimei Health Technology

A number of institutional investors and hedge funds have recently made changes to their positions in AFJK. Wellspring Financial Advisors LLC acquired a new position in shares of Aimei Health Technology during the 2nd quarter valued at about $133,000. Jane Street Group LLC acquired a new stake in Aimei Health Technology in the 4th quarter worth approximately $302,000. Dakota Wealth Management bought a new stake in Aimei Health Technology during the fourth quarter worth approximately $406,000. Geode Capital Management LLC acquired a new position in Aimei Health Technology during the fourth quarter valued at approximately $413,000. Finally, Clear Street LLC raised its position in shares of Aimei Health Technology by 63.8% in the second quarter. Clear Street LLC now owns 39,525 shares of the company’s stock valued at $441,000 after purchasing an additional 15,399 shares during the period. Institutional investors and hedge funds own 45.58% of the company’s stock.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.